Instadose Pharma Corp. (INSD)

USD 0.0

(0.0%)

Net Debt Summary of Instadose Pharma Corp.

Instadose Pharma Corp.'s latest annual net debt in 2023 was - USD , down 0.0% from previous year.
Instadose Pharma Corp.'s latest quarterly net debt in 2024 Q1 was - USD , down 0.0% from previous quarter.
Instadose Pharma Corp. reported annual net debt of - USD in 2022, up 100.0% from previous year.
Instadose Pharma Corp. reported annual net debt of -84.40 USD in 2021, down -100.15% from previous year.
Instadose Pharma Corp. reported quarterly net debt of - USD for 2023 Q4, down 0.0% from previous quarter.
Instadose Pharma Corp. reported quarterly net debt of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Net Debt Chart of Instadose Pharma Corp. (2023 - 2017)

Historical Annual Net Debt of Instadose Pharma Corp. (2023 - 2017)

Year	Net Debt	Net Debt Growth
2023	- USD	0.0%
2022	- USD	100.0%
2021	-84.40 USD	-100.15%
2020	55.57 Thousand USD	70.5%
2019	32.59 Thousand USD	210.4%
2018	10.5 Thousand USD	203.4%
2017	-10.15 Thousand USD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	- USD	0.0%
2023 Q4	- USD	0.0%
2023 Q2	- USD	0.0%
2023 Q3	- USD	0.0%
2023 FY	- USD	0.0%
2023 Q1	- USD	0.0%
2022 Q3	232.19 Thousand USD	0.0%
2022 FY	- USD	100.0%
2022 Q1	- USD	100.0%
2022 Q2	- USD	0.0%
2021 FY	-84.40 USD	-100.15%
2021 Q4	-6.04 USD	86.46%
2021 Q1	-124.28 USD	28.32%
2021 Q3	-44.60 USD	47.16%
2021 Q2	-84.40 USD	32.09%
2020 Q4	-173.38 USD	-100.3%
2020 FY	55.57 Thousand USD	70.5%
2020 Q3	57.23 Thousand USD	2.82%
2020 Q2	55.66 Thousand USD	12.7%
2020 Q1	49.39 Thousand USD	13.06%
2019 Q3	40 Thousand USD	22.71%
2019 Q2	32.59 Thousand USD	11.4%
2019 Q1	29.26 Thousand USD	27.46%
2019 FY	32.59 Thousand USD	210.4%
2019 Q4	43.68 Thousand USD	9.21%
2018 Q4	22.95 Thousand USD	18.65%
2018 Q2	10.5 Thousand USD	34.03%
2018 Q3	19.35 Thousand USD	84.26%
2018 Q1	7835.68 USD	77.11%
2018 FY	10.5 Thousand USD	203.4%
2017 FY	-10.15 Thousand USD	0.0%
2017 Q4	4424.14 USD	0.0%

Peer Net Debt Comparison of Instadose Pharma Corp.

Name	Net Debt	Net Debt Difference
BioQuest Corp.	177.38 Thousand USD	100.0%
GSRX Industries Inc.	- USD	NaN%
High Sierra Technologies, Inc.	469.78 Thousand USD	100.0%